PED Is Overexpressed and Mediates TRAIL Resistance in Human Non-Small Cell Lung Cancer

Journal of Cellular and Molecular Medicine - United Kingdom
doi 10.1111/j.1582-4934.2008.00283.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Nociceptin Receptor Is Overexpressed in Non-Small Cell Lung Cancer and Predicts Poor Prognosis

Frontiers in Oncology
Cancer ResearchOncology
2019English

Interferon Regulatory Factor 4 (IRF4) Is Overexpressed in Human Non‑small Cell Lung Cancer (NSCLC) and Activates the Notch Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Overexpressed LAPTM4B-35 Is a Risk Factor for Cancer Recurrence and Poor Prognosis in Non-Small-Cell Lung Cancer

Oncotarget
Oncology
2016English

Overexpression of OCT4 Is Associated With Gefitinib Resistance in Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Acquired EGFR C797S Mutation Mediates Resistance to AZD9291 in Non–small Cell Lung Cancer Harboring EGFR T790M

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

2020English

Non-Small Cell Lung Cancer

English

POLR1B Is Upregulated and Promotes Cell Proliferation in Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer

Frontiers in Pharmacology
Pharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy